Skip to main content
Log in

Psychotherapy for obsessive-compulsive disorder

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Cognitive-behavioral therapy (CBT) with exposure and response prevention is a first-line intervention for adult and childhood obsessive-compulsive disorder. Methodologically rigorous controlled trials have suggested that benefits from CBT exceed those from placebo and attention-control conditions and have similar or greater efficacy than serotonergic monotherapy. This article reviews the nature of CBT and associated outcome data, highlighting recent empiric findings in the treatment literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Abramowitz JS, Whiteside SP, Deacon BJ: The effectiveness of treatment for pediatric obsessive-compulsive disorder. Behav Ther 2005, 36:55–63.

    Article  Google Scholar 

  2. Pediatric OCD Treatment Study (POTS) Team: Cognitivebehavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004, 292:1969–1976.

    Article  Google Scholar 

  3. Foa EB, Liebowitz MR, Kozak MJ, et al.: Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005, 162:151–161.

    Article  PubMed  Google Scholar 

  4. Barlow DH: Anxiety and its Disorders. New York: Guilford Press; 1988.

    Google Scholar 

  5. Clark DM: A cognitive approach to panic. Behav Res Ther 1986, 24:461–470.

    Article  PubMed  CAS  Google Scholar 

  6. Rapee RM, Heimberg RG: A cognitive-behavioral model of anxiety in social phobia. Behav Res Ther 1997, 35:741–756.

    Article  PubMed  CAS  Google Scholar 

  7. Foa EB, Kozak MJ: Treatment of anxiety disorders: implications for psychopathology. In Anxiety and the Anxiety Disorders. Edited by Tuma AH, Maser JD. Mahwah, NJ: Lawrence Erlbaum Associates; 1985:421–452.

    Google Scholar 

  8. Salkovskis PM: Obsessional-compulsive problems: a cognitivebehavioural analysis. Behav Res Ther 1985, 23:571–583.

    Article  PubMed  CAS  Google Scholar 

  9. March JS, Franklin M, Nelson A, Foa E: Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder. J Clin Child Psychol 2001, 30:8–18.

    Article  PubMed  CAS  Google Scholar 

  10. Barrett PD, Farrell L, Pina AA, et al.: Evidence-based psychosocial treatments for child and adolescent obsessive-compulsive disorder. J Clin Child Adolesc Psychol 2008, 37:131–155.

    Article  PubMed  Google Scholar 

  11. Franklin ME, Foa EB: Cognitive-behavioral treatments for obsessive-compulsive disorder. In A Guide to Treatments That Work. Edited by Nathan PE, Gorman JM. London: Oxford University Press; 2002:367–386.

    Google Scholar 

  12. American Academy of Child and Adolescent Psychiatry (AACAP): Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998, 37:527–545.

    Google Scholar 

  13. Foa EB, Kozak MJ: Psychological treatments for obsessivecompulsive disorder. In Long-term Treatments of Anxiety Disorders. Edited by Mavissakalian MR, Prien RF. Washington, DC: American Psychiatric Association; 1996:285–309.

    Google Scholar 

  14. Franklin ME, Abramowitz JS, Kozak MJ, et al.: Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. J Consult Clin Psychol 2000, 68:594–602.

    Article  PubMed  CAS  Google Scholar 

  15. Black DW: Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders. CNS Spect 2006, 11(10 Suppl 12):29–33.

    Google Scholar 

  16. March JS, Benton CM: Talking Back to OCD: The Program That Helps Kids and Teens Say “No Way”—and Parents Say “Way to Go.” New York: Guilford Press; 2007.

    Google Scholar 

  17. Valderhaug R, Larsson B, Gotestam KG, Piacentini J: An open clinical trial of cognitive-behaviour therapy in children and adolescents with obsessive-compulsive disorder administered in regular outpatient clinics. Behav Res Ther 2007, 45:577–589.

    Article  PubMed  Google Scholar 

  18. Abramowitz JS, Foa EB, Franklin ME: Exposure and ritual prevention for obsessive-compulsive disorder: effectiveness of intensive versus twice-weekly treatment sessions. J Consult Clin Psychol 2003, 71:394–398.

    Article  PubMed  Google Scholar 

  19. Franklin ME, Kozak MJ, Cashman LA, et al.: Cognitivebehavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial. J Am Acad Child Adolesc Psychiatry 1998, 37:412–419.

    Article  PubMed  CAS  Google Scholar 

  20. Storch EA, Geffken GR, Merlo LJ, et al.: Family-based cognitive-therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 2007, 46:469–478.

    Article  PubMed  Google Scholar 

  21. Foa EB, Franklin ME, Kozak MJ: Psychosocial treatment of obsessive-compulsive disorder: literature review. In Obsessive-Compulsive Disorder: Theory, Research, and Treatment. Edited by Swinson RP, Antony MM, Rachman S, Richter MA. New York: Guilford Press; 1998:258–276.

    Google Scholar 

  22. Salkovskis PM, Forrester E, Richards C: Cognitivebehavioural approach to understanding obsessional thinking. Br J Psychiatry 1998, 173:53–66.

    Google Scholar 

  23. Krochmalik A, Jones MK, Menzies RG: Danger ideation reduction therapy (DIRT) for treatment-resistant compulsive washing. Behav Res Ther 2001, 39:897–912.

    Article  PubMed  CAS  Google Scholar 

  24. van Oppen P, de Haan E, van Balkom A, et al.: Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther 1995, 33:379–390.

    Article  PubMed  Google Scholar 

  25. Wilhelm S, Steketee G, Reilly-Harrington NA, et al.: Effectiveness of cognitive therapy for obsessive-compulsive disorder: an open trial. J Cogn Psychother 2005, 19:173–179.

    Article  Google Scholar 

  26. Wilson KA, Chambless DL: Cognitive therapy for obsessivecompulsive disorder. Behav Res Ther 2005, 43:1645–1654.

    Article  PubMed  Google Scholar 

  27. Freeman JB, Garcia AM, Coyne L, et al.: Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach. J Am Acad Child Adolesc Psychiatry 2008, 47:593–602.

    Article  PubMed  Google Scholar 

  28. Barrett P, Healy-Farrell L, March JS: Cognitive-behavioral treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry 2004, 43:46–62.

    Article  PubMed  Google Scholar 

  29. Whiteside SP, Brown AM, Abramowitz JS: Five-day intensive treatment for adolescent OCD: a case series. J Anxiety Disord 2008, 22:495–504.

    Article  PubMed  Google Scholar 

  30. Rowa K, Antony MM, Summerfeldt LJ, et al.: Office-based vs. home-based behavioral treatment for obsessive-compulsive disorder: a preliminary study. Behav Res Ther 2007, 45:1883–1892.

    Article  PubMed  Google Scholar 

  31. Tolin DF, Hannan S, Maltby N, et al.: A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials. Behav Ther 2007, 38:179–191.

    Article  PubMed  Google Scholar 

  32. Anderson RA, Rees CS: Group versus individual cognitivebehavioural treatment for obsessive-compulsive disorder: a controlled trial. Behav Res Ther 2007, 45:123–137.

    Article  PubMed  Google Scholar 

  33. Ginsberg GS, Kingery JN, Drake KL, Grados MA: Predictors of treatment response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008, 47:868–878.

    Article  Google Scholar 

  34. Storch EA, Merlo LJ, Larson MJ, et al.: Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008, 47:583–592.

    Article  PubMed  Google Scholar 

  35. Hansen B, Vogel PA, Stiles TC, Götestam KG: Influence of co-morbid generalized anxiety disorder, panic disorder and personality disorders on the outcome of cognitive behavioural treatment of obsessive-compulsive disorder. Cogn Behav Ther 2007, 36:145–155.

    Article  PubMed  Google Scholar 

  36. Storch EA, Merlo LJ, Larson MJ, et al.: Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder. Acta Psychiatr Scand 2008, 117:67–75.

    PubMed  CAS  Google Scholar 

  37. Diefenbach GJ, Abramowitz JS, Norberg MM, Tolin DF: Changes in quality of life following cognitive-behavioral therapy for obsessive-compulsive disorder. Behav Res Ther 2007, 45:3060–3068.

    Article  PubMed  Google Scholar 

  38. Storch EA, Murphy TK, Lack CW, et al.: Sleep-related problems in pediatric obsessive-compulsive disorder. J Anxiety Disord 2008, 22:877–885.

    Article  PubMed  Google Scholar 

  39. Walker DL, Ressler KJ, Lu KT, Davis M: Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 2002, 22:2343–2351.

    PubMed  CAS  Google Scholar 

  40. Ledgerwood L, Richardson R, Cranney J: Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci 2003, 117:341–349.

    Article  PubMed  CAS  Google Scholar 

  41. Ledgerwood L, Richardson R, Cranney J: D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci 2004, 118:505–513.

    Article  PubMed  Google Scholar 

  42. Ledgerwood L, Richardson R, Cranney J: D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry 2005, 57:841–847.

    Article  PubMed  CAS  Google Scholar 

  43. Ressler KJ, Rothbaum BO, Tannenbaum L, et al.: Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004, 61:1136–1144.

    Article  PubMed  Google Scholar 

  44. Hofmann SG, Pollack MH, Otto MW: Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Rev 2006, 12:208–217.

    Article  PubMed  CAS  Google Scholar 

  45. Wilhelm S, Buhlmann U, Tolin DF, et al.: Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 2008, 165:335–341.

    Article  PubMed  Google Scholar 

  46. Kushner MG, Kim SW, Donahue C, et al.: D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry 2007, 62:835–838.

    Article  PubMed  CAS  Google Scholar 

  47. Storch EA, Merlo LJ, Bengtson M, et al.: D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol 2007, 22:230–237.

    Article  PubMed  Google Scholar 

  48. Simpson HB, Foa EB, Liebowitz MR, et al.: A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry 2008, 165:621–630.

    Article  PubMed  Google Scholar 

  49. Simpson HB, Zuckoff A, Page JR, et al.: Adding motivational interviewing to exposure and ritual prevention for obsessive-compulsive disorder: an open pilot trial. Cogn Behav Ther 2008, 37:38–49.

    Article  PubMed  Google Scholar 

  50. Tolin DF, Maltby N, Diefenbach GJ, et al.: Cognitivebehavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. J Clin Psychiatry 2004, 65:922–931.

    Article  PubMed  Google Scholar 

  51. Fritzler BK, Hecker JE, Losee MC: Self-directed treatment with minimal therapist contact: preliminary findings for obsessive-compulsive disorder. Behav Res Ther 1997, 35:627–631.

    Article  PubMed  CAS  Google Scholar 

  52. Tolin DF, Diefenbach GJ, Maltby N, Hannan SE: Stepped care for obsessive-compulsive disorder: a pilot study. Cogn Behav Pract 2005, 12:403–414.

    Article  Google Scholar 

  53. Greist JH, Marks IM, Baer L, et al.: Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry 2002, 63:138–145.

    PubMed  Google Scholar 

  54. Tolin DF, Hannan S, Maltby N, et al.: A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials. Behav Ther 2007, 38:179–191.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric A. Storch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Storch, E.A., Mariaskin, A. & Murphy, T.K. Psychotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep 11, 296–301 (2009). https://doi.org/10.1007/s11920-009-0043-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-009-0043-8

Keywords

Navigation